CI Global Longevity Economy Fund (LONG.TO) focuses on investments that capitalize on the aging population and longevity trends, particularly in sectors like healthcare, technology, and consumer goods. Its competitive position is strengthened by a specialized investment strategy targeting companies that are well-positioned to benefit from demographic shifts in North America and Europe.
The fund generates revenue primarily through management fees calculated as a percentage of AUM, which is influenced by market performance and inflows. It also earns performance fees when returns exceed benchmark indices, leveraging its expertise in identifying high-growth opportunities in the longevity economy.
Changes in demographics and aging population trends in North America and Europe
Performance of underlying investments in healthcare and technology sectors
Market sentiment towards ESG and longevity-focused investments
Regulatory changes impacting asset management and investment strategies
Technological disruption in healthcare and financial services could impact investment strategies
Regulatory changes affecting asset management and investment products
Increased competition from other funds targeting the longevity economy
Market entry of new players with innovative investment strategies
Liquidity risks associated with market downturns affecting AUM
Potential for increased operational costs due to regulatory compliance
moderate - The fund's performance is somewhat tied to economic cycles, as consumer spending on healthcare and related services can fluctuate with economic conditions.
Rising interest rates can impact the valuation of growth-oriented investments, potentially leading to lower multiples. However, higher rates may also increase demand for fixed-income products, which could diversify the fund's offerings.
minimal - The fund is not heavily reliant on credit markets for its operations.
growth - Investors looking for exposure to demographic trends and long-term growth opportunities in the longevity economy.
moderate - The fund's performance may exhibit moderate volatility due to market fluctuations in the healthcare and technology sectors.